CNS-Campus Neurologico Senior

Torres Vedras 2560-280

0 studies enrolling now · 4 studies all time

What they study most

Alzheimer's Disease, MSA, MSA - Multiple System Atrophy, Parkinson's Disease, Parkinson's Disease (PD), Pure Autonomic Failure (PAF), Symptomatic Neurogenic Orthostatic Hypotension

Studies at this site

• Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy — Running, not enrolling
• Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations — Running, not enrolling
• A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
• Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure — Stopped early